Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Magnetic resonance images (MRI) of the brain exhibit high dimensionality that pose significant challenges for computational analysis. While models proposed for brain MRIs analyses yield encouraging results, the high complexity of neuroimaging data hinders generalizability and clinical application. We introduce DUNE, a neuroimaging-oriented encoder designed to extract deep-features from multisequen...
Comprehensively studying modifiable risk factors altogether to explore how they contribute to dementia mechanism is imperative for effective interventions. This study utilized natural language processing (NLP) models to pre-select candidate risk factors of dementia from 5,505 variables in the UK Biobank. We then took a holistic machine learning approach, fast causal inference in combination with m...
The increasing availability of whole-genome sequencing (WGS) has begun to elucidate the contribution of rare variants (RVs), both coding and non-codin...
Age is a significant risk factor for mild cognitive impairment (MCI) and Alzheimer’s disease (AD) and identifying brain age patterns is critical for c...
Mechanical ventilation (MV) is a critical competency in critical care training, yet standardized methods for assessing MV-related knowledge are lackin...
Accurately predicting which individuals with mild cognitive impairment (MCI) will progress to Alzheimer’s disease (AD) can improve patient care. This ...
The growing use of large language models for health communication raises important questions about patient preferences, trust, and satisfaction with A...
Genetic variants associated with Alzheimer’s disease (AD) through genome-wide association studies (GWAS) are challenging to interpret because most lie...
Machine learning applied to neuroimaging can help with medical diagnosis and early detection by identifying biomarkers of subtle changes in brain stru...
Recent work leveraging artificial intelligence has offered promise to dissect disease heterogeneity by identifying complex intermediate brain phenotyp...
Neurodegenerative diseases are characterized by complex proteins misfolded that propagate within the brain. For instance, current findings highlight t...
Alzheimer’s disease (AD) and AD-related dementias (ADRD) exhibit heterogeneous progression rates, with rapid progression (RP) posing significant chall...
Positron Emission Tomography (PET) scans are a crucial tool in the diagnosing and monitoring of a number of complex conditions, including cancer, hear...
Alzheimer’s disease (AD) and Schizophrenia (SCZ) exhibit overlapping clinical features and biological mechanisms, but the extent of their shared genet...
Metabolic biomarkers can potentially be used for early diagnosis, prognostic risk stratification and/or early treatment and prevention of individuals ...
The TOMM40’523 poly-T repeat polymorphism (rs10524523), located in the TOMM40 gene and in linkage disequilibrium with APOE, has been associated with c...
Alzheimer’s disease (AD), particularly late-onset AD, stands as the most prevalent neurodegenerative disorder globally. Owing to its substantial herit...
Predicting the early onset of dementia due to Alzheimer’s Disease (AD) has major implications for timely clinical management and outcomes. Current dia...
Dementia with Lewy bodies (DLB) is frequently misdiagnosed as Alzheimer’s disease (AD) due to overlapping clinical presentations. In this study, we ev...
Primary age-related tauopathy (PART) and Alzheimer’s disease (AD) share hippocampal phospho-tau (p-tau) pathology but differ in ß-amyloid burden and d...